Takeda Pharmaceutical Co Ltd
Takeda Pharmaceutical Co Ltd/ US8740602052 /
TAK
|
23/05/2024 18:17:03
|
Diferencia
-0.01
|
Volumen |
Bid18:17:55 |
Ask18:17:55 |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
|
13.05USD
|
-0.08%
|
9,592
Volumen de negocios: 125,214.56 |
13.04Volumen de oferta: 100 |
13.05Tamaño/ Volumen/ Formato de Ask: 300 |
48.82 mil millonesUSD |
- |
- |
Descripción de negocio
Located in Osaka, Japan, Takeda (TYO: 4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine.
Consejo de gestión & Consejo de supervisión
| CEO |
| Christophe Weber |
| Consejo de gestión |
| Costa Saroukos, Akiko Amakawa, Elaine Shannon, Gabriele Ricci, Giles Platford, Julie Kim, Lauren Duprey, Marcello Agosti, Milano Furuta, Mwana Lugogo, Ramona Sequeira, Takako Ohyabu, Teresa Bitetti, Thomas Wozniewski, Yoshihiro Nakagawa |
| Consejo de supervisión |
| Christophe Weber, Costa Saroukos, Dr. Andrew Plump, Emiko Higashi, Ian Clark, Jean-Luc Butel, Koji Hatsukawa, Michel Orsinger, Olivier Bohuon, Yoshiaki Fujimori, Masami Iijima, Steven Gillis, John Maraganore, Miki Tsusaka, Kimberly A. Reed |
Datos de la empresa
| Nombre: |
Takeda Pharmaceutical Company Ltd. |
| Dirección: |
1-1, Nihonbashi-Honcho 2-Chome,Chuo-ku, Tokyo 103-8668, Japan |
| Teléfono: |
+81-3-3278-2306 |
| Fax: |
+81-3-3278-2268 |
| E-mail: |
-
|
| Internet: |
www.takeda.com/ |
| Industria: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Subsector: |
Pharmaceuticals |
| Fin del año financiero: |
31/03 |
| Acciones de libre circulación: |
- |
| Fecha de OPI: |
- |
Relación con inversores
| Nombre: |
Christopher O'Reilly |
| IR teléfono: |
+81-3-3278-2037 |
| IR-fax: |
+81-3-3278-2741 |
| IR e-mail: |
takeda.ir.contact@takeda.com
|
